MrsGemma McErlean

Gemma has authored >70 peer-reviewed publications and has secured >$3M in competitive research grant and industry/partnership funding. Her work has been recognised through major awards and competitive programs, including two NSW Premier's Award recognitions for Outstanding Cancer Research (Early Career) - finalist in 2024 and nominee in 2023 - the University of Sydney Peter Bancroft Prize, a University of Sydney Postgraduate Award (UPA), a Clinical Oncology Society of Australia (COSA) Survivorship Fellowship, and a Winston Churchill Memorial Trust Fellowship focused on best-practice Blood and Marrow Transplant long-term follow-up survivorship models in world-leading international centres. She contributes to national influence and workforce development through senior professional leadership roles with the Cancer Nurses Society of Australia (CNSA), including as President (June 2026–), Co-Vice President (June 2025–June 2026), Director of Research (2024–2025), and Director of Education (2021–2023). She also holds council and committee roles spanning clinical ethics, cancer research translation, and nursing research strategy. She also holds council and committee roles spanning clinical ethics (SESLHD Clinical Ethics Committee), cancer research translation, and nursing research strategy (SESLHD), including as a member of the Cancer Australia Intercollegiate Advisory Group, the COSA Council (CNSA Representative), and the Australian Cancer Nursing and Navigation Program (ACNNP) Expert Advisory Group.